| Description | Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others. |
| molecular weight | 299.35 |
| Molecular formula | C15H13N3O2S |
| CAS | 1007581-62-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 11 mg/mL (36.75 mM) |
| References | 1. Thomas, et al. OXAZOLIDONE DERIVATIVES AS PR MODULATORS. WO 2008021331 A2. |